Researchers at the University of Southern California have uncovered a surprising new function of the Nup98 protein that might revolutionize cancer treatment approaches. While previously recognized for its role in molecular transport through the cell nucleus, Nup98 is now revealed to play a vital part in DNA repair. This mechanism is crucial for preventing the genetic abnormalities that can lead to cancer or premature aging.
The study, led by scientists Irene Chiolo and Chiara Merigliano and published in Molecular Cell, highlights how Nup98 forms unique droplet-like structures, or condensates, around damaged DNA segments within heterochromatin. Heterochromatin comprises densely packed genome regions that are notoriously difficult to repair accurately because of their repetitive sequences, raising the risk of errors. Nup98 encapsulates the damaged DNA, facilitating its safe transport to repair zones. This encapsulation process ensures that the repair proteins, such as Rad51, are triggered at the optimal time, preventing misalignment of DNA segments. As a result, the repair process becomes more precise, aiding in maintaining genomic stability and potentially slowing pathological processes linked to cancer and aging.
This groundbreaking discovery has profound implications, especially concerning diseases like acute myeloid leukemia, where Nup98 mutations are involved. Understanding Nup98’s new role might enable the development of targeted therapies that can either utilize its functions to eradicate cancer cells or counteract the effects of mutations.
In conclusion, identifying Nup98’s unexpected function in DNA repair opens up exciting possibilities for crafting innovative cancer treatments and deepening our comprehension of genomic stability. Future research could yield treatments designed to enhance or mimic Nup98’s capabilities, offering new hopes in the fight against diseases associated with genome instability, such as cancer and other age-related conditions. This discovery emphasizes the importance of investigating cellular processes that were previously assumed to be secondary, potentially revealing novel therapeutic targets.